HD-OPM Archive
Topics › Aging & longevity

USC receives NIH grant to study thymulin and inflammaging

Louis Nervegna · Aug 05, 2026 · ♥ 2 reactions · 1 comments · original Facebook post
Aging & longevityInflammation & CRP
AI summary & key facts

Keck School of Medicine researchers received a 5-year, $3.2 million grant to study thymulin, a thymus hormone that restrains age-related chronic inflammation.

#thymusHD #thymulinHD #inflammationHD #inflammagingHD #agingHD #cancerHD

A hormone made in a small organ behind your breastbone could hold the key to helping older adults respond better to cancer treatment.

Keck School of Medicine of USC researchers have received a five-year, $3.2 million grant from the National Institutes of Health to study thymulin, a hormone produced by the thymus that keeps chronic inflammation, sometimes called "inflammaging," under control as we age.

The team, led by Fumito Ito, MD, PhD, previously found that thymulin reduced inflammation and improved survival in older mice with cancer. Now they will test whether it can strengthen immunotherapies like anti-PD-1 and anti-PD-L1 treatments and help slow metastatic cancer, with the goal of developing therapies that work better for the older patients who make up most cancer cases.

Anatomical illustration of a human upper torso. The image shows transparent lungs with highlighted thymus gland in red, set against a dark blue background.
← newer: Statin users had 14% lower dementia risk in a meta-analysis older: Thymulin from the thymus dampens age-related inflammation →